Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Phys Rehabil Med ; 54(5): 757-765, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29185676

ABSTRACT

INTRODUCTION: Cerebral palsy is a group of movement and posture development disorders. 90% of this population has gait impairment, often due to the presence of spasticity. A number of studies emphasize the importance of combined physical therapy with botulinum toxin A treatment. However, no consensus can be reached concerning the content of the physiotherapy program after treatment with botulinum toxin A. The purpose of the present study was to investigate, through a systematic review of the literature, the effects of physiotherapeutic intervention on gait after botulinum toxin application in children with cerebral palsy. EVIDENCE ACQUISITION: PubMed, Scielo, Cochrane Library, OTseeker, and PEDro databases were searched for randomized trial published between January 2000 and January 2017. EVIDENCE SYNTHESIS: Sixty-eight articles were identified, four of which met the eligibility criteria and were selected for the present systematic review. A table was created showing the main characteristics of the studies (groups, inclusion criteria, dosage, injection site, physiotherapeutic intervention, evaluation and outcomes). CONCLUSIONS: This study offers a view on the increase in the therapeutic effectiveness of botulinum toxin A on the lower limbs when used in conjunction with a physiotherapeutic intervention, with improvements in mobility, gait pattern, range of motion and spasticity, which are maintained after the end of the physical therapy protocol. The use of botulinum toxin A on the lower limbs when used in conjunction with a physiotherapeutic intervention, can improve muscle tone, allowing a combined treatment and intended to provide improvement of motor ability and functional skills, and potentially, delay the need for surgery.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Cerebral Palsy/physiopathology , Muscle Spasticity/drug therapy , Neuromuscular Agents/therapeutic use , Physical Therapy Modalities , Botulinum Toxins, Type A/administration & dosage , Child , Combined Modality Therapy , Gait , Humans , Neuromuscular Agents/administration & dosage , Range of Motion, Articular
SELECTION OF CITATIONS
SEARCH DETAIL
...